1. Home
  2. CYTK vs VIST Comparison

CYTK vs VIST Comparison

Compare CYTK & VIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.52

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Vista Energy S.A.B. de C.V. each representing one series A share with no par value

VIST

Vista Energy S.A.B. de C.V. each representing one series A share with no par value

HOLD

Current Price

$65.79

Market Cap

6.3B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
VIST
Founded
1997
2017
Country
United States
Mexico
Employees
N/A
515
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.3B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
VIST
Price
$60.52
$65.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
3
Target Price
$87.56
$74.33
AVG Volume (30 Days)
1.7M
1.6M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$302.66
$31.86
P/E Ratio
N/A
$7.99
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$32.11
52 Week High
$70.98
$66.77

Technical Indicators

Market Signals
Indicator
CYTK
VIST
Relative Strength Index (RSI) 42.12 68.77
Support Level $59.25 $53.80
Resistance Level $65.93 N/A
Average True Range (ATR) 2.76 2.52
MACD -0.35 0.48
Stochastic Oscillator 18.21 91.74

Price Performance

Historical Comparison
CYTK
VIST

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value

Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.

Share on Social Networks: